Bright Historical Cash Flow
| DRUG Stock | USD 39.18 1.07 2.81% |
Analysis of Bright Minds cash flow over time is an excellent tool to project Bright Minds Biosciences future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Other Non Cash Items of 40.3 K or Capital Expenditures of 6.04 as it is a great indicator of Bright Minds ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining Bright Minds Biosciences latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Bright Minds Biosciences is a good buy for the upcoming year.
Bright |
About Bright Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in Bright balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Bright's non-liquid assets can be easily converted into cash.
Bright Minds Cash Flow Chart
Add Fundamental
Stock Based Compensation
Compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders.Most accounts from Bright Minds' cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Bright Minds Biosciences current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Bright Minds Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment. At this time, Bright Minds' Change To Liabilities is most likely to increase significantly in the upcoming years. The Bright Minds' current Change To Account Receivables is estimated to increase to about 143.4 K, while Free Cash Flow is projected to decrease to (6.6 M).
| 2020 | 2021 | 2023 | 2024 (projected) | Change To Liabilities | 506.2K | 766.0K | 880.9K | 924.9K | Change To Netincome | 1.0M | 647.7K | 744.8K | 548.8K |
Bright Minds cash flow statement Correlations
Click cells to compare fundamentals
Bright Minds Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Bright Minds cash flow statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change In Cash | 719.9K | 19.0M | (8.1M) | (4.9M) | (4.4M) | (4.2M) | |
| Free Cash Flow | (288.4K) | (7.3M) | (13.6M) | (7.0M) | (6.3M) | (6.6M) | |
| Change In Working Capital | 30.7K | 306.1K | 726.3K | (941.7K) | (847.5K) | (805.2K) | |
| Other Cashflows From Financing Activities | 1.0K | (1.7M) | 1.2M | 1.1M | 1.2M | 1.3M | |
| Other Non Cash Items | 161.3K | 144.8K | (229.6K) | 65.1K | 58.6K | 40.3K | |
| Total Cash From Operating Activities | (288.4K) | (7.3M) | (13.6M) | (7.0M) | (6.3M) | (6.6M) | |
| Net Income | (480.4K) | (8.7M) | (15.0M) | (7.4M) | (6.6M) | (7.0M) | |
| Total Cash From Financing Activities | 1.0M | 26.1M | 5.2M | 2.2M | 2.5M | 2.4M | |
| End Period Cash Flow | 799.9K | 19.8M | 11.6M | 6.7M | 7.8M | 8.6M |
Currently Active Assets on Macroaxis
When determining whether Bright Minds Biosciences is a strong investment it is important to analyze Bright Minds' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Bright Minds' future performance. For an informed investment choice regarding Bright Stock, refer to the following important reports:Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Bright Minds Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bright Minds. If investors know Bright will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bright Minds listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.63) | Return On Assets (0.29) | Return On Equity (0.52) |
The market value of Bright Minds Biosciences is measured differently than its book value, which is the value of Bright that is recorded on the company's balance sheet. Investors also form their own opinion of Bright Minds' value that differs from its market value or its book value, called intrinsic value, which is Bright Minds' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bright Minds' market value can be influenced by many factors that don't directly affect Bright Minds' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bright Minds' value and its price as these two are different measures arrived at by different means. Investors typically determine if Bright Minds is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bright Minds' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.